SINPHAR — AGM Information 2021

Aug 19, 2021

Meeting Notice

for

Annual Shareholders’ Meeting

(Summary Translation)

The 2021 Annual Shareholders’ Meeting (the “Meeting”) of Sinphar Pharmaceutical Co.,Ltd. (the “Company”) will be convened at 10:00 a.m., Tuesday, June 23, 2021 at Talent Training Center 1st Training Room (located at No.95, Xinliao Rd., Dongshan Township, Yilan County 269, Taiwan (R.O.C.))

1. The agenda for the Meeting is as follows:

   • I. Report Items

   • (1) Business operations report: 2020

   • (2) Supervisor’s review report on the 2020 financial statements

(3) 2020 Distribution of Employee Remuneration and Directors' and

Supervisors' Remunerations

• (4) Others operations report

II. Items for Approval

(1) Operational financial statements and reports: 2020

(2) Proposal for 2020 Deficit Compensation

III. Items for Discussion and Election

• (1) To approve the proposal for 2020 distribution of capital surplus

(2) Election of the Directors.

List of candidates for directors:

Name	Education	Experience	Present position	Shareholding
Chih Wen,Lee	BA, SchoolofPharmacy,Kaoshiung	Director,Institute forBiotechnologyand Medicine	Chairman,SinpharPharmaceuticalCo., Ltd.	3,149,791

	MedicalUniversity	Industry(IBMI)Chairman,SinpharPharmaceuticalCo., Ltd.
Hsiu Min,Lin	National IlanInstitute ofAgricultureandTechnology	Director,SinpharPharmaceuticalCo., Ltd.	Director,SinpharPharmaceuticalCo., Ltd.	1,336,876
Hsiu Chi,Kuo	KainanVocationalHigh School	Chairman,GloryNutria Ltd.Chairman,VIT-GUTE NutritionLtd.Director,SinpharPharmaceuticalCo., Ltd.	Chairman,GloryNutria Ltd.Chairman,VIT-GUTE NutritionLtd.Director,SinpharPharmaceuticalCo., Ltd.	2,064,382
Ling Mo,Chao	TaichungMunicipalShaluIndustrialHigh School	Chairman,GiantGoal LeatherMFG. Inc.Director,SinpharPharmaceuticalCo., Ltd.	Chairman,GiantGoal LeatherMFG. Inc.Director,SinpharPharmaceuticalCo., Ltd.	1,498,547
RepresentingXing-DAVentureCapitalCorporation：Yita Lee	N/A	RepresentingSinpharPharmaceuticalCo., Ltd.	RepresentingSinpharPharmaceuticalCo., Ltd.	15,470,464
Hung Chih,Lin	BS,Departmentof ChemicalEngineering,	Chairman,Daxie BoutiqueDepartmentStore Co., Ltd.	Supervisor,SinpharPharmaceuticalCo., Ltd.	1,000,128

	ChineseCultureUniversity	Chairman,Jian-Sheng Co., Ltd.
ZhengZhe,Guan	Ph.D.,Graduate Institudeof SunYat-senStudies,ChineseCultureUniversity	DeputyDirector-general, NationalPolice Agency,Ministry of theInterior R.O.C.	Supervisor,SinpharPharmaceuticalCo., Ltd.	0
NengChun, Yu	BA, ChinaMedicalUniversity,Taiwan	President,TaiwaneseAssociation ofDiabetesEducators(TADE)HonoraryPresident, YilanAssociation ofDiabetesSupporters	Supervisor,SinpharPharmaceuticalCo., Ltd.Superintendent,NENG-CHUNDIABETESCLINIC	999,763

List of candidates for independent directors:

Name	Education	Experience	Present position	Shareholding
ChingLung, Lee	Ph.D.,Horticulture,LeibnizUniversitätHannover,Germany.	Professor,National TaiwanUniversityChair Professor,National ChungHsingUniversityNational policyadvisor to thePresident	Professor,National TaiwanUniversityChair Professor,National ChungHsing University	0
Yao Yuan,Wen	Master,College ofLaw,	AdministrationChief Judge&Chief Judge,	IndependentDirector,Sinphar	0

	NationalTaiwanUniversity	Taiwan HighCourtChief Judge,Taiwan MiaoliDistrict Court	PharmaceuticalCo., Ltd.Director, CJWInternationalCo., Ltd.IndependentDirector,AMIDATechnology, Inc.
Hsin YuChou	DepartmentofAccounting,AletheiaUniversity	SeniorManager,Crowe (TW)CPAsFinanceDirector,SABRINAFASHIONINDUSTRIALCORP.	none	0

IV. Other Discussion Items:

• (1) Release the Prohibition on Directors from Participation in Competitive Business.

Release the Prohibition on Directors from Participation in Competitive Business.

Director	Concurrent Positions Held at Other Companies	Concurrent Positions Held at Other Companies
Hsiu Chi, Kuo	Chairman,GloryNutriaLtd.	president of the board
	Chairman,VIT-GUTENutrition Ltd.	president of the board

1. The major items of the proposal for 2020 distribution of capital surplus adopted at Board of Directors meeting are as follows:

The Board has adopted a major proposal for 2020 distribution of capital surplus is as follows:

The Board of Directors has proposed to distribute capital surplus of NT$ 0.2 per share. The board proposed that shareholders’ meeting authorize the Board of Directors to resolve the adjustments of the

actual capital surplus distribution determined by the shareholding ratio of shareholders on the basis of the number of issued and outstanding stocks registered in the Common Stockholders’ Roster as record date.

Board of Directors Sinphar Pharmaceutical Co.,Ltd.